Zeinab El-Dirani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Zeinab El-Dirani has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
Catherine Williamson
Department of Obstetric Medicine, St Thomas’ Hospital, London, UK
3 shared publications- Chaza Akik
Affiliation Faculty of Health Sciences, Center for Research on Population and Health, American University of Beirut, Beirut, Lebanon
3 shared publications Christelle Akl
Affiliation Center for Research on Population and Health, Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon
3 shared publicationsJoan Devin
School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland
3 shared publicationsMelanie Nana
Department of Women & Children’s Health, School of Life Course & Population Sciences, King’s College London, London, UK
3 shared publications- Stephen J. McCall
American University of Beirut
3 shared publications
Latest Publications
- Open Access
- 9 November 2026
- Published by Springer Nature in Reproductive Health
Preconception experiences of women after hyperemesis gravidarum: a qualitative study
- 9 November 2026
- Published by Springer Nature in Reproductive Health
Open AccessPreconception experiences of women after hyperemesis gravidarum: a qualitative study
- Open Access
- 29 August 2026
- Published by Elsevier in Sexual & Reproductive Healthcare
- Vol. 49
Exploring the postpartum recovery after hyperemesis gravidarum: A qualitative study
- 29 August 2026
- Published by Elsevier in Sexual & Reproductive Healthcare
- Vol. 49
Open AccessExploring the postpartum recovery after hyperemesis gravidarum: A qualitative study
- Open Access
- 31 March 2026
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 175 (1) , 48-55
Hyperemesis gravidarum and oral health: A scoping review
Background: Hyperemesis gravidarum (HG) is a severe form of nausea and vomiting in pregnancy (NVP), associated with dehydration, nutritional deficiencies, and systemic complications. Although recurrent vomiting, altered dietary patterns, and medication effects might plausibly affect oral health, this relationship has not been comprehensively synthesized. Objective: The objective of this scoping review is to systematically map the existing evidence on the association between HG and oral health. Eligibility Criteria: Primary studies of any design examining oral health in individuals with HG or severe nausea and vomiting in pregnancy (meeting HG‐level severity criteria) were included. Editorials, commentaries, studies of mild or moderate nausea and vomiting in pregnancy (NVP), and studies without oral health findings were excluded. Sources of Evidence: Seven electronic databases (PubMed/MEDLINE, Embase, CINAHL, Scopus, Web of Science, OVID Medline, and the Cochrane Library) were searched in October 2025. Additional sources included gray literature from HG‐focused organizations (e.g., HER Foundation and Pregnancy Sickness Support) and reference lists of included studies. Charting Methods: Screening was conducted independently by two reviewers following reviewer calibration, using Covidence software for reference management and deduplication. Full texts were assessed independently by two reviewers, with disagreements resolved through discussion or third‐reviewer adjudication. A pre‐piloted data charting form was used to extract study characteristics, oral health assessment methods, and key findings related to HG. Data were synthesized narratively and reported in accordance with Preferred Reporting Items for Systematic Reviews and Meta‐Analyses extension for Scoping Reviews guidelines. Results: The search identified 2697 records, with 1752 remaining after deduplication. Of 38 full‐text articles screened, 10 studies met the inclusion criteria. Study designs included cross‐sectional ( n = 3), case reports ( n = 3), case–control ( n = 2), and retrospective cohort studies ( n = 2). Across all studies, a total of 8630 participants were represented (range 1–7765; median 34.5). Periodontal status was clinically assessed in one study, which found significantly worse periodontal indices in HG compared with controls, and one additional study reported higher self‐reported gum disease in individuals with HG. Dental cavities were self‐reported in one study, showing higher pre‐ and post‐pregnancy prevalence among those with HG. Three studies described hypersalivation consistent with ptyalism gravidarum, frequently co‐occurring with HG, while salivary biomarkers were assessed in two studies. One study reported enamel hypoplasia in children born to mothers with severe HG. Self‐reported oral hygiene difficulties were described in six studies, and one study noted higher levels of self‐reported temporomandibular joint disorder in HG participants. Conclusion: This scoping review identifies a substantial gap in evidence linking HG with oral health conditions. Available studies suggest challenges in maintaining oral hygiene practices, alongside frequent gastric acid exposure, which might heighten risk for oral complications, but robust clinical data are lacking. Further research and interdisciplinary attention are needed to clarify and address these associations.
- 31 March 2026
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 175 (1) , 48-55
Open AccessHyperemesis gravidarum and oral health: A scoping review
Background: Hyperemesis gravidarum (HG) is a severe form of nausea and vomiting in pregnancy (NVP), associated with dehydration, nutritional deficiencies, and systemic complications. Although recurrent vomiting, altered dietary patterns, and medication effects might plausibly affect oral health, this relationship has not been comprehensively synthesized. Objective: The objective of this scoping review is to systematically map the existing evidence on the association between HG and oral health. Eligibility Criteria: Primary studies of any design examining oral health in individuals with HG or severe nausea and vomiting in pregnancy (meeting HG‐level severity criteria) were included. Editorials, commentaries, studies of mild or moderate nausea and vomiting in pregnancy (NVP), and studies without oral health findings were excluded. Sources of Evidence: Seven electronic databases (PubMed/MEDLINE, Embase, CINAHL, Scopus, Web of Science, OVID Medline, and the Cochrane Library) were searched in October 2025. Additional sources included gray literature from HG‐focused organizations (e.g., HER Foundation and Pregnancy Sickness Support) and reference lists of included studies. Charting Methods: Screening was conducted independently by two reviewers following reviewer calibration, using Covidence software for reference management and deduplication. Full texts were assessed independently by two reviewers, with disagreements resolved through discussion or third‐reviewer adjudication. A pre‐piloted data charting form was used to extract study characteristics, oral health assessment methods, and key findings related to HG. Data were synthesized narratively and reported in accordance with Preferred Reporting Items for Systematic Reviews and Meta‐Analyses extension for Scoping Reviews guidelines. Results: The search identified 2697 records, with 1752 remaining after deduplication. Of 38 full‐text articles screened, 10 studies met the inclusion criteria. Study designs included cross‐sectional ( n = 3), case reports ( n = 3), case–control ( n = 2), and retrospective cohort studies ( n = 2). Across all studies, a total of 8630 participants were represented (range 1–7765; median 34.5). Periodontal status was clinically assessed in one study, which found significantly worse periodontal indices in HG compared with controls, and one additional study reported higher self‐reported gum disease in individuals with HG. Dental cavities were self‐reported in one study, showing higher pre‐ and post‐pregnancy prevalence among those with HG. Three studies described hypersalivation consistent with ptyalism gravidarum, frequently co‐occurring with HG, while salivary biomarkers were assessed in two studies. One study reported enamel hypoplasia in children born to mothers with severe HG. Self‐reported oral hygiene difficulties were described in six studies, and one study noted higher levels of self‐reported temporomandibular joint disorder in HG participants. Conclusion: This scoping review identifies a substantial gap in evidence linking HG with oral health conditions. Available studies suggest challenges in maintaining oral hygiene practices, alongside frequent gastric acid exposure, which might heighten risk for oral complications, but robust clinical data are lacking. Further research and interdisciplinary attention are needed to clarify and address these associations.
- Open Access
- 27 May 2025
- Published by Springer Nature in Maternal and Child Health Journal
- Vol. 29 (6) , 767-776
Interventions Initiated Before and After Pregnancy for Women who Experience Severe Nausea and Vomiting of Pregnancy: A Scoping Review
Introduction: Nausea and vomiting of pregnancy (NVP) affects up to 90% of women, while hyperemesis gravidarum (HG), a severe form of NVP, impacts quality of life, and ability to eat and drink normally, with reported recurrence rates up to 89% in subsequent pregnancies. Severe NVP has a profound impact on maternal physical and mental health, impairing daily functioning and quality of life, and is associated with anxiety and depression. Aims: To conduct a scoping review to identify and characterise interventions initiated before and after pregnancy that aim to mitigate the impact and consequences of severe NVP on maternal health. Methods: A comprehensive search was conducted across seven electronic databases and included grey literature without restrictions on language or date. Eligible studies were identified according to a prespecified criteria. All references were screened independently by two reviewers. Findings: Three studies were included; two utilised pre-emptive counselling and antiemetic treatment beginning before pregnancy or in early pregnancy/upon recognition of pregnancy, while one focused on post-pregnancy writing therapy. Both pre-emptive interventions reported a reduction in NVP symptom severity and a lower recurrence rate of HG, while writing therapy was beneficial in aiding recovery from severe NVP and allowed women an opportunity to externalise and process the experience. Discussion: This study revealed a paucity of interventions initiated before and after pregnancy for women with severe NVP. The included studies showed some benefits of pre-emptive treatment and writing therapy. Conclusion: Tailored pre-pregnancy and postpartum interventions for women with previous severe NVP are urgently needed to address the physical and mental health burden of the condition.
- 27 May 2025
- Published by Springer Nature in Maternal and Child Health Journal
- Vol. 29 (6) , 767-776
Open AccessInterventions Initiated Before and After Pregnancy for Women who Experience Severe Nausea and Vomiting of Pregnancy: A Scoping Review
Introduction: Nausea and vomiting of pregnancy (NVP) affects up to 90% of women, while hyperemesis gravidarum (HG), a severe form of NVP, impacts quality of life, and ability to eat and drink normally, with reported recurrence rates up to 89% in subsequent pregnancies. Severe NVP has a profound impact on maternal physical and mental health, impairing daily functioning and quality of life, and is associated with anxiety and depression. Aims: To conduct a scoping review to identify and characterise interventions initiated before and after pregnancy that aim to mitigate the impact and consequences of severe NVP on maternal health. Methods: A comprehensive search was conducted across seven electronic databases and included grey literature without restrictions on language or date. Eligible studies were identified according to a prespecified criteria. All references were screened independently by two reviewers. Findings: Three studies were included; two utilised pre-emptive counselling and antiemetic treatment beginning before pregnancy or in early pregnancy/upon recognition of pregnancy, while one focused on post-pregnancy writing therapy. Both pre-emptive interventions reported a reduction in NVP symptom severity and a lower recurrence rate of HG, while writing therapy was beneficial in aiding recovery from severe NVP and allowed women an opportunity to externalise and process the experience. Discussion: This study revealed a paucity of interventions initiated before and after pregnancy for women with severe NVP. The included studies showed some benefits of pre-emptive treatment and writing therapy. Conclusion: Tailored pre-pregnancy and postpartum interventions for women with previous severe NVP are urgently needed to address the physical and mental health burden of the condition.
- Open Access
- 6 December 2023
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 3 (12) , e0001383
Patient experiences of diabetes and hypertension care during an evolving humanitarian crisis in Lebanon: A qualitative study
Humanitarian health care models increasingly incorporate care for non-communicable diseases (NCDs). Current research evidence focuses on burden of disease, service provision and access to care, and less is known about patient’s experience of the continuum of care in humanitarian settings. To address this gap, this study explored experiences of displaced Syrian and vulnerable Lebanese patients receiving care for hypertension and/or diabetes at four health facilities supported by humanitarian organisations in Lebanon. We conducted in-depth, semi-structured qualitative interviews with a purposive sample of patients (n = 18) and their informal caregivers (n = 10). Data were analysed thematically using both deductive and inductive approaches. Both Syrian and Lebanese patients reported interrupted pathways of care. We identified three typologies of patient experience at the time of interview; (1) managing adequately from the patient’s perspective; (2) fragile management and (3) unable to manage their condition(s) adequately, with the majority falling into typologies 2 and 3. Patients and their families recognised the importance of maintaining continuity of care and self-management, but experienced substantial challenges due to changing availability and cost of medications and services, and decreasing economic resources during a period of national crises. Family support underpinned patient’s response to challenges. Navigating the changing care landscape was a significant burden for patients and their families. Interactions were identified between mental health and NCD management. This study suggests that patients experienced disrupted, non-linear pathways in maintaining care for hypertension and diabetes in a humanitarian setting, and family support networks were key in absorbing treatment burden and sustaining NCD management. Recommendations are made to reduce treatment burden for patients and their families and to support sustainable condition management.
- 6 December 2023
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 3 (12) , e0001383
Open AccessPatient experiences of diabetes and hypertension care during an evolving humanitarian crisis in Lebanon: A qualitative study
Humanitarian health care models increasingly incorporate care for non-communicable diseases (NCDs). Current research evidence focuses on burden of disease, service provision and access to care, and less is known about patient’s experience of the continuum of care in humanitarian settings. To address this gap, this study explored experiences of displaced Syrian and vulnerable Lebanese patients receiving care for hypertension and/or diabetes at four health facilities supported by humanitarian organisations in Lebanon. We conducted in-depth, semi-structured qualitative interviews with a purposive sample of patients (n = 18) and their informal caregivers (n = 10). Data were analysed thematically using both deductive and inductive approaches. Both Syrian and Lebanese patients reported interrupted pathways of care. We identified three typologies of patient experience at the time of interview; (1) managing adequately from the patient’s perspective; (2) fragile management and (3) unable to manage their condition(s) adequately, with the majority falling into typologies 2 and 3. Patients and their families recognised the importance of maintaining continuity of care and self-management, but experienced substantial challenges due to changing availability and cost of medications and services, and decreasing economic resources during a period of national crises. Family support underpinned patient’s response to challenges. Navigating the changing care landscape was a significant burden for patients and their families. Interactions were identified between mental health and NCD management. This study suggests that patients experienced disrupted, non-linear pathways in maintaining care for hypertension and diabetes in a humanitarian setting, and family support networks were key in absorbing treatment burden and sustaining NCD management. Recommendations are made to reduce treatment burden for patients and their families and to support sustainable condition management.
- Top Cited PapersOpen Access
- 1 September 2022
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 19 (9) , e1004061
The global prevalence of female genital mutilation/cutting: A systematic review and meta-analysis of national, regional, facility, and school-based studies
Background: Female genital mutilation/cutting (FGM/C) is a nonmedical procedure entailing the modification of the external female genitalia. A description of the prevalence and distribution of FGM/C allows the tracking of progress toward ending FGM/C by 2030 (Sustainable Development Goal (SDG): target 5.3). This systematic review aimed to examine FGM/C prevalence and types, by World Health Organization (WHO) region and country. Methods and findings: A systematic search using Medical Subject Headings (MeSH) and keywords from 2009 to March 24, 2022 was undertaken in MEDLINE, PubMED, PsycINFO, Web of Science, and Embase to identify studies presenting FGM/C prevalence. Abstract and full-text screening, quality assessment, and data extraction were undertaken by 2 reviewers. Only nationally representative studies were included in the meta-analysis. Pooled FGM/C prevalence was estimated by random-effects meta-analysis using generalized linear mixed models (GLMMs). FGM/C prevalence with 95% confidence intervals (CIs), prediction intervals (PIs), and FGM/C type were presented separately by women aged 15 to 49 years and girls aged 0 to 14 years. A total of 163 studies met the inclusion criteria and 30 were included in the meta-analysis, of which 23 were from the WHO African Region (AFR), 6 from the Eastern Mediterranean Region (EMR), and 1 from the South East Asian Region (SEAR). These studies included data from 406,068 women across 30 countries and 296,267 girls across 25 countries; the pooled prevalence estimate of FGM/C among women aged 15 to 49 years was 36.9% (95% CI: 19.6% to 58.3%; PI: 0.4% to 99.0%), and 8.27% (95% CI: 3.7% to 17.3%; PI: 0.1% to 89.3%) among girls aged 0 to 14 years. Among included countries, this gave a total estimated prevalence of 84,650,032 women (95% CI: 45,009,041 to 133,834,224) and 13,734,845 girls with FGM/C (95% CI: 6,211,405 to 28,731,901). Somalia had the highest FGM/C prevalence among women (99.2%), and Mali had the highest among girls (72.7%). The most common type of FGM/C among women was “flesh removed” (Type I or II) in 19 countries. Among girls, “not sewn closed” (Type I, II, or IV) and “flesh removed” (Type I or II) were the most common types in 8 countries, respectively. Among repeated nationally representative studies, FGM/C decreased for both women and girls in 26 countries. The main limitation of the study methodology is that estimates were based on available published data, which may not reflect the actual global prevalence of FGM/C. Conclusions: In this study, we observed large variation in FGM/C prevalence between countries, and the prevalence appears to be declining in many countries, which is encouraging as it minimizes physical and physiological harm for a future generation of women. This prevalence estimate is lower than the actual global prevalence of FGM/C due to data gaps, noncomparable denominators, and unavailable surveys. Yet, considerable policy and community-level interventions are required in many countries to meet the SDG target 5.3. Trial registration: Registration: CRD42020186937.
- 1 September 2022
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 19 (9) , e1004061
Top Cited PapersOpen AccessThe global prevalence of female genital mutilation/cutting: A systematic review and meta-analysis of national, regional, facility, and school-based studies
Background: Female genital mutilation/cutting (FGM/C) is a nonmedical procedure entailing the modification of the external female genitalia. A description of the prevalence and distribution of FGM/C allows the tracking of progress toward ending FGM/C by 2030 (Sustainable Development Goal (SDG): target 5.3). This systematic review aimed to examine FGM/C prevalence and types, by World Health Organization (WHO) region and country. Methods and findings: A systematic search using Medical Subject Headings (MeSH) and keywords from 2009 to March 24, 2022 was undertaken in MEDLINE, PubMED, PsycINFO, Web of Science, and Embase to identify studies presenting FGM/C prevalence. Abstract and full-text screening, quality assessment, and data extraction were undertaken by 2 reviewers. Only nationally representative studies were included in the meta-analysis. Pooled FGM/C prevalence was estimated by random-effects meta-analysis using generalized linear mixed models (GLMMs). FGM/C prevalence with 95% confidence intervals (CIs), prediction intervals (PIs), and FGM/C type were presented separately by women aged 15 to 49 years and girls aged 0 to 14 years. A total of 163 studies met the inclusion criteria and 30 were included in the meta-analysis, of which 23 were from the WHO African Region (AFR), 6 from the Eastern Mediterranean Region (EMR), and 1 from the South East Asian Region (SEAR). These studies included data from 406,068 women across 30 countries and 296,267 girls across 25 countries; the pooled prevalence estimate of FGM/C among women aged 15 to 49 years was 36.9% (95% CI: 19.6% to 58.3%; PI: 0.4% to 99.0%), and 8.27% (95% CI: 3.7% to 17.3%; PI: 0.1% to 89.3%) among girls aged 0 to 14 years. Among included countries, this gave a total estimated prevalence of 84,650,032 women (95% CI: 45,009,041 to 133,834,224) and 13,734,845 girls with FGM/C (95% CI: 6,211,405 to 28,731,901). Somalia had the highest FGM/C prevalence among women (99.2%), and Mali had the highest among girls (72.7%). The most common type of FGM/C among women was “flesh removed” (Type I or II) in 19 countries. Among girls, “not sewn closed” (Type I, II, or IV) and “flesh removed” (Type I or II) were the most common types in 8 countries, respectively. Among repeated nationally representative studies, FGM/C decreased for both women and girls in 26 countries. The main limitation of the study methodology is that estimates were based on available published data, which may not reflect the actual global prevalence of FGM/C. Conclusions: In this study, we observed large variation in FGM/C prevalence between countries, and the prevalence appears to be declining in many countries, which is encouraging as it minimizes physical and physiological harm for a future generation of women. This prevalence estimate is lower than the actual global prevalence of FGM/C due to data gaps, noncomparable denominators, and unavailable surveys. Yet, considerable policy and community-level interventions are required in many countries to meet the SDG target 5.3. Trial registration: Registration: CRD42020186937.
- 2 July 2022
- Published by Taylor & Francis in Mental Health, Religion & Culture
- Vol. 25 (6) , 592-608
Fasting while on antipsychotics: an exploration of the decision-making process of Muslim patients during Ramadan
Fasting during the holy month of Ramadan is one of the five pillars of Islam. Adherents to the Muslim faith are expected to abstain from drinking or eating during daylight hours. Exclusions to fasting apply, including for medical reasons. There is no consensus on the specific implications for psychiatric conditions. This qualitative study explores the decision-making process of Muslim patients on antipsychotic treatment with regard to fasting during Ramadan. The sample consisted of eleven outpatients actively treated at three psychiatric clinics in Lebanon. They were asked about the different factors that influence their decision to fast or not. Most participants prioritized their personal interpretation of the religious dogma. The opinion of the psychiatrist was important but not always readily available. The wider community, including religious figures, had the least influence. The findings highlight an important role for psychiatrists in proactively supporting patients in their decision on fasting in Ramadan.
- 2 July 2022
- Published by Taylor & Francis in Mental Health, Religion & Culture
- Vol. 25 (6) , 592-608
Fasting while on antipsychotics: an exploration of the decision-making process of Muslim patients during Ramadan
Fasting during the holy month of Ramadan is one of the five pillars of Islam. Adherents to the Muslim faith are expected to abstain from drinking or eating during daylight hours. Exclusions to fasting apply, including for medical reasons. There is no consensus on the specific implications for psychiatric conditions. This qualitative study explores the decision-making process of Muslim patients on antipsychotic treatment with regard to fasting during Ramadan. The sample consisted of eleven outpatients actively treated at three psychiatric clinics in Lebanon. They were asked about the different factors that influence their decision to fast or not. Most participants prioritized their personal interpretation of the religious dogma. The opinion of the psychiatrist was important but not always readily available. The wider community, including religious figures, had the least influence. The findings highlight an important role for psychiatrists in proactively supporting patients in their decision on fasting in Ramadan.
- Top Cited PapersOpen Access
- 9 March 2022
- Published by BMJ in BMJ Sexual & Reproductive Health
- Vol. 48 (3) , 169-178
Factors associated with female genital mutilation: a systematic review and synthesis of national, regional and community-based studies
Background This systematic review aimed to identify and describe the factors that influence female genital mutilation/cutting (FGM/C). Methods Searches were conducted in Medline, PsycInfo, Web of Science, Embase and the grey literature from 2009 to March 2020 with no language restrictions, using related MESH terms and keywords. Studies were included if they were quantitative and examined factors associated with FGM/C. Two researchers independently screened studies for inclusion, extracted data and assessed study quality. The direction, strength and consistency of the association were evaluated for determinants, presented as a descriptive summary, and were disaggregated by age and region. Results Of 2230 studies identified, 54 published articles were included. The majority of studies were from the African Region (n=29) followed by the Eastern Mediterranean Region (n=18). A lower level of maternal education, family history of FGM/C, or belonging to the Muslim religion (in certain contexts) increased the likelihood of FGM/C. The majority of studies that examined higher paternal education (for girls only) and living in an urban region showed a reduced likelihood of FGM/C, while conflicting evidence remained for wealth. Several studies reported that FGM/C literacy, and low community FGM/C prevalence were associated with a reduced likelihood of FGM/C. Conclusions There were several characteristics that appear to be associated with FGM/C, and these will better enable the targeting of policies and interventions. Importantly, parental education may be instrumental in enabling communities and countries to meet the Sustainable Development Goals.
- 9 March 2022
- Published by BMJ in BMJ Sexual & Reproductive Health
- Vol. 48 (3) , 169-178
Top Cited PapersOpen AccessFactors associated with female genital mutilation: a systematic review and synthesis of national, regional and community-based studies
Background This systematic review aimed to identify and describe the factors that influence female genital mutilation/cutting (FGM/C). Methods Searches were conducted in Medline, PsycInfo, Web of Science, Embase and the grey literature from 2009 to March 2020 with no language restrictions, using related MESH terms and keywords. Studies were included if they were quantitative and examined factors associated with FGM/C. Two researchers independently screened studies for inclusion, extracted data and assessed study quality. The direction, strength and consistency of the association were evaluated for determinants, presented as a descriptive summary, and were disaggregated by age and region. Results Of 2230 studies identified, 54 published articles were included. The majority of studies were from the African Region (n=29) followed by the Eastern Mediterranean Region (n=18). A lower level of maternal education, family history of FGM/C, or belonging to the Muslim religion (in certain contexts) increased the likelihood of FGM/C. The majority of studies that examined higher paternal education (for girls only) and living in an urban region showed a reduced likelihood of FGM/C, while conflicting evidence remained for wealth. Several studies reported that FGM/C literacy, and low community FGM/C prevalence were associated with a reduced likelihood of FGM/C. Conclusions There were several characteristics that appear to be associated with FGM/C, and these will better enable the targeting of policies and interventions. Importantly, parental education may be instrumental in enabling communities and countries to meet the Sustainable Development Goals.
- Open Access
- 4 September 2021
- Published by BMJ in Journal of Epidemiology and Community Health
- Vol. 75 (Suppl 1) , A10.2-A11
OP22 The global prevalence of female genital mutilation: a systematic review and meta-analysis of nationally representative studies
Background Female Genital Mutilation (FGM) entails the removal, cutting and modification of the external female genitalia for non-medical reasons. The UN Sustainable Development Goal 5 (SDG 5.3) on gender equality calls for ending all traditional harmful practices, including FGM by 2030. This systematic review examined the prevalence of FGM and its subtypes globally, by WHO region, and by country. Methods A systematic search using MeSH headings and keywords from inception to March 2, 2020 was undertaken in MEDLINE, PsycINFO, Web of Science, and EMBASE to identify studies that presented data on FGM prevalence. Only nationally representative studies were included in the meta-analysis. Abstract and full-text screening, quality assessment, and data extraction were undertaken independently by two reviewers. Pooled FGM prevalence was estimated by meta-analysis using a Freeman-Tukey double arcsine transformation and a random effects model using R software. FGM prevalence and types of FGM were presented separately by women and girls. Sub-group analysis was presented by WHO region. Results Out of 3205 articles identified in the search, 28 nationally representative studies were included in the meta-analysis, and these studies included estimates for women and girls in 27 and 34 countries, respectively.The pooled prevalence estimate of FGM in women aged 15–49 was 40% (95% CI:26–55%; I2 =100%) and 15% (95% CI:10–21%; I2 =100%) in girls aged 0–14 years old. The country with the highest FGM prevalence in women was Guinea (97%) and the lowest, Uganda (0.3%). The highest prevalence in girls was in Mali (77%), and the lowest in Ghana (0%). The most common FGM type was having flesh removed, at 69% (95% CI:59–79%) of women and 70% (95% CI: 55–84%) of girls, followed by having the genital area sewn shut with 11% of women (95% CI:4–20%) and 9% of girls (95% CI:6–12%). The pooled prevalence by WHO region was 39% (95% CI: 24–56%) for women and 15% (95% CI:9–22%) for girls in Africa, and 52% (95% CI:8–93%) for women and 20% (95% CI:6–39%) for girls in the Eastern Mediterranean. Conclusion There is large global variation in FGM, with the Eastern Mediterranean region recording the highest prevalence. Reassuringly, FGM is lower among girls, highlighting a declining trend in the practice. Some included reports may have underestimated FGM prevalence in girls due to continued risk; future studies should use age cohort analyses to monitor decline. Policy and community-level interventions are needed to meet SDG target 5.3.
- 4 September 2021
- Published by BMJ in Journal of Epidemiology and Community Health
- Vol. 75 (Suppl 1) , A10.2-A11
Open AccessOP22 The global prevalence of female genital mutilation: a systematic review and meta-analysis of nationally representative studies
Background Female Genital Mutilation (FGM) entails the removal, cutting and modification of the external female genitalia for non-medical reasons. The UN Sustainable Development Goal 5 (SDG 5.3) on gender equality calls for ending all traditional harmful practices, including FGM by 2030. This systematic review examined the prevalence of FGM and its subtypes globally, by WHO region, and by country. Methods A systematic search using MeSH headings and keywords from inception to March 2, 2020 was undertaken in MEDLINE, PsycINFO, Web of Science, and EMBASE to identify studies that presented data on FGM prevalence. Only nationally representative studies were included in the meta-analysis. Abstract and full-text screening, quality assessment, and data extraction were undertaken independently by two reviewers. Pooled FGM prevalence was estimated by meta-analysis using a Freeman-Tukey double arcsine transformation and a random effects model using R software. FGM prevalence and types of FGM were presented separately by women and girls. Sub-group analysis was presented by WHO region. Results Out of 3205 articles identified in the search, 28 nationally representative studies were included in the meta-analysis, and these studies included estimates for women and girls in 27 and 34 countries, respectively.The pooled prevalence estimate of FGM in women aged 15–49 was 40% (95% CI:26–55%; I2 =100%) and 15% (95% CI:10–21%; I2 =100%) in girls aged 0–14 years old. The country with the highest FGM prevalence in women was Guinea (97%) and the lowest, Uganda (0.3%). The highest prevalence in girls was in Mali (77%), and the lowest in Ghana (0%). The most common FGM type was having flesh removed, at 69% (95% CI:59–79%) of women and 70% (95% CI: 55–84%) of girls, followed by having the genital area sewn shut with 11% of women (95% CI:4–20%) and 9% of girls (95% CI:6–12%). The pooled prevalence by WHO region was 39% (95% CI: 24–56%) for women and 15% (95% CI:9–22%) for girls in Africa, and 52% (95% CI:8–93%) for women and 20% (95% CI:6–39%) for girls in the Eastern Mediterranean. Conclusion There is large global variation in FGM, with the Eastern Mediterranean region recording the highest prevalence. Reassuringly, FGM is lower among girls, highlighting a declining trend in the practice. Some included reports may have underestimated FGM prevalence in girls due to continued risk; future studies should use age cohort analyses to monitor decline. Policy and community-level interventions are needed to meet SDG target 5.3.